tiprankstipranks
Innovative Pharmaceutical Biotech Limited (HK:0399)
:0399
Hong Kong Market

Innovative Pharmaceutical Biotech (0399) Income Statement

Compare
0 Followers

Innovative Pharmaceutical Biotech Income Statement

Last quarter (Q4 2023), Innovative Pharmaceutical Biotech's total revenue was HK$1.43M, a decrease of -27.20% from the same quarter last year. In Q4, Innovative Pharmaceutical Biotech's net income was HK$-90.28M. See Innovative Pharmaceutical Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 24Mar 23Mar 22Mar 21Mar 20
Total Revenue
HK$ 6.59MHK$ 8.07MHK$ 11.14MHK$ 15.19MHK$ 14.58M
Gross Profit
HK$ 840.00KHK$ 858.00KHK$ 1.05MHK$ 1.41MHK$ 1.62M
Operating Expenses
HK$ 14.27MHK$ 21.56MHK$ 25.49MHK$ 22.79MHK$ 33.98M
Depreciation and Amortization
HK$ 941.00KHK$ 1.88MHK$ 2.13MHK$ 2.31MHK$ 1.24M
EBITDA
HK$ 317.75MHK$ -18.82MHK$ -22.30MHK$ -18.81MHK$ -80.49M
Operating Income
HK$ -13.43MHK$ -20.70MHK$ -24.35MHK$ -21.34MHK$ -26.02M
Other Income/Expenses
HK$ 112.14MHK$ -233.97MHK$ 60.78MHK$ -190.77MHK$ -190.10M
Pretax Income
HK$ 98.71MHK$ -254.67MHK$ 36.43MHK$ -212.16MHK$ -222.46M
Net Income
HK$ 103.40MHK$ -245.70MHK$ 296.54MHK$ -395.75MHK$ -407.56M
Per Share Metrics
HK$ ―HK$ ―HK$ ―HK$ ―HK$ ―
Basic EPS
HK$ -0.01HK$ -0.17HK$ 0.20HK$ -0.27HK$ -0.28
Diluted EPS
HK$ -0.01HK$ -0.17HK$ 0.17HK$ -0.27HK$ -0.28
Weighted Average Shares Outstanding
1.53B 1.46B 1.46B 1.46B 1.46B
Weighted Average Shares Outstanding (Diluted)
2.50B 1.46B 1.75B 1.46B 1.46B
Currency in HKD

Innovative Pharmaceutical Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis